过氧化物增生体激活受体-γ激动剂抑制腹膜间皮细胞转化生长因子-β_1的表达

下载PDF

导出

作者刘虹彭佑铭刘伏友

机构地区中南大学湘雅二医院肾内科

出处《肾脏病与透析肾移植杂志》 CAS CSCD 2005年第2期154-155,共2页 Chinese Journal of Nephrology,Dialysis & Transplantation

参考文献6

1Yung S,Liu ZH,Li LS,et al.Emodin ameliorates glucose-induced excess matrix synthesis by human peritoneal mesothelial cells(Abstract).Perit Dial Int,2002,21:S23.
2Asano T, Wakisaka M, Yoshinari M,et al.Peroxisome proliferator-activated receptor gamma1(PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists mdulati its differentiation. Blochim Biophys Acta,2000,1497:148-154.
3Ma LJ, Marcantoni C, Linton MF,et al.Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int,2001,59:1899-1910.
4Eleni S, Lucy AJ, Malcolm D,et al.Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int,1990,37:1563-1570.
5黄一新,徐琴君,吴亚农.不卧床持续性腹膜透析患者血浆和透析排出液中细胞因子的变化及意义[J].肾脏病与透析肾移植杂志,2000,9(2):135-137. 被引量：4
6McCarthy KJ, Routh RE, Shaw W,et al.Troglitazone hlts diabetic glomerulosclerosis by blockade of mesangial expansion. Kidney Int,2000,58:2341-2350.

1吴平勇,张庆红,张建鄂,李涛,张永,王顺华,李新华.高通量透析可改善维持性血液透析患者肾性贫血[J].生物医学工程与临床,2005,9(1):40-44. 被引量：9
2赵志宏,韩立中.腹膜透析液658例培养病原菌分布及耐药性分析[J].中国药物与临床,2015,15(3):424-425. 被引量：1
3刘虹,彭佑铭,刘伏友.环氧化酶-2抑制剂对人腹膜间皮细胞转化生长因子-β_1表达的影响[J].肾脏病与透析肾移植杂志,2003,12(6):512-515. 被引量：2

肾脏病与透析肾移植杂志

2005年第2期

内容加载中请稍等...